Back
MoonLake Immunotherapeutics Stock Price Chart
5 Stocks to Consider Immediately (must-see chart)
See the green days for 5 major stocks right here, free of charge
Buy
66
MLTX
MoonLake Immunotherapeutics
Last Price:
$47.65
Seasonality Move:
19.44%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
The current trend is moderately bullish and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.31 | Buy |
| 20-day SMA: | 45.85 | Buy |
| 50-day SMA: | 42.39 | Buy |
| 200-day SMA: | 45.6 | Buy |
| 8-day EMA: | 47.18 | Buy |
| 20-day EMA: | 45.65 | Buy |
| 50-day EMA: | 43.43 | Buy |
| 200-day EMA: | 43.97 | Buy |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.59 | Buy |
| Relative Strength Index (14 RSI): | 66.2 | Buy |
| Chaikin Money Flow: | 106562 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.48 - 48.38) | Buy |
| Bollinger Bands (100): | (37.37 - 44.69) | Buy |
MoonLake Immunotherapeutics Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 48.89 while MLTX 8-day simple moving average is 47.31, which is a Buy signal.
-
The stock price of MLTX is 48.89 while MoonLake Immunotherapeutics 20-day SMA is 45.85, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day simple moving average is 42.39 while MLTX share price is 48.89, making it a Buy technically.
-
MLTX stock price is 48.89 and MoonLake Immunotherapeutics 200-day simple moving average is 45.60, creating a Buy signal.
MLTX Technical Analysis vs Fundamental Analysis
Buy
66
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a BuyThe current MoonLake Immunotherapeutics [MLTX] share price is $48.89. The Score for MLTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
3.1B
Price in USD:
48.89
Share Volume:
244.1K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
58.26
52-Week Low:
31.42
Buy
66
MoonLake Immunotherapeutics (MLTX)
is a Buy
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 48.89 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is not overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 48.89 while MLTX 8-day exponential moving average is 47.18, which is a Buy signal.
-
The stock price of MLTX is 48.89 while MoonLake Immunotherapeutics 20-day EMA is 45.65, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 43.43 while MLTX share price is 48.89, making it a Buy technically.
-
MLTX stock price is 48.89 and MoonLake Immunotherapeutics 200-day simple moving average is 43.97, creating a Buy signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is 1.59, suggesting MoonLake Immunotherapeutics is a Buy
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 66.2, which suggest MoonLake Immunotherapeutics is overbought
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (42.48 - 48.38), which suggest MoonLake Immunotherapeutics is a Buy
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (37.37 - 44.69), which suggest MoonLake Immunotherapeutics is a Buy
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.